Incidence of Deep Vein Thrombosis at Doppler Echo in Covid-19 Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-04-24

Study Completion Date

2021-06-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective of the study is to determine the incidence of deep vein thromboses at Doppler echo in patients with SARS-Cov-2 pneumopathy upon their entry into ICU and after 7 days of hospitalization in ICU.

This is a monocentric interventional study (RIPH 2).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prevalence of DVT or PE in Patients Infected With COVID-19 Admitted to Hospital

NCT04380792

COVID-19

COMPLETED

Prediction of Thrombosis Using D-dimer Trends in COVID-19

NCT04827160

Covid19

COMPLETED

COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic Complications

NCT04535128

Covid19 Thrombosis Embolism DVT +3 more

COMPLETED

Coronavirus Disease (COvid-)19 REgistry on THROMBOSIS Complications

NCT04780295

Covid19

COMPLETED

Analysis of the Coagulopathy Developed by COVID-19 Infected Patients

NCT04356950

Sepsis Blood Coagulation Disorders Thrombin +2 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Deep Vein Thrombosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Doppler Echo

patients will have a Doppler Echo when they enter ICU (within 48 hours) and a second Doppler Echo 7 days later

Group Type OTHER

Doppler Echo

Intervention Type OTHER

2 doppler echo will be done at patients hospitalized in ICU and with SARS-CoV-2 pneumopathy at 7 days apart

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Doppler Echo

2 doppler echo will be done at patients hospitalized in ICU and with SARS-CoV-2 pneumopathy at 7 days apart

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient \> or =18 years
* Hospitalization in intensive care
* PCR COVID 19+ or compatible clinical signs (fever, cough, myalgia, asthenia, loss of taste, anosmia) associated with compatible radiological signs

Exclusion Criteria

* Pregnancy in progress
* Patient \<18 years
* Patients deprived of freedoms or under guardianship
* Patient or family opponent of protocol participation
* patient on curative anticoagulant for more than 48H00
* impossible Venous Doppler Echo

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No